dr donna h ryan glp-1 Today is World Obesity Day.🌎, According to @worldobesity, over 1 billion people worldwide are living with obesity, and projections show that 4 billion people are expected to be living with overweight FREE Webinar - The Obesity

Customization is also limited

doi: 10.5847/wjem.j.issn.1920-8642.2014.02.011 [DOI] [PMC free article] [PubMed] [Google Scholar] 173

Comparing Ozempic and Mounjaro SideBySide Ozempic : Proven GLP1 therapy with reliable appetite reduction and moderate weight loss Mounjaro : Dual-action GLP1/GIP therapy, delivering stronger metabolic impact and bigger weight loss Your health history, weight goals, and preferences guide the choice, so having both options available ensures you get the perfect fit

But weight loss can be a side effect of both medications

Reviews highlight strong engagement during onboarding and early care